Brust-Zentrum AG

Zurich 8008

0 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, HER2 Positive Breast Cancer

Studies at this site

• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer — Running, not enrolling